Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
270 Vision is a UK private medtech and digital health company developing medical-grade wearable sensor systems and body-motion analysis software for injury prevention, rehabilitation, and remote patient assessment. Its core commercial offerings include BPMpathway for clinician-led remote orthopaedic recovery monitoring and WPMpro for workplace musculoskeletal risk detection using autonomous wearable sensors. The company has also described ongoing development of sensor-based solutions for elite sports and long-term care. 270 Vision appears to operate as a healthcare-focused wearable technology and analytics platform business rather than a therapeutics developer, with products built around proprietary motion-sensing, data analysis, and charging technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 270 Vision.